Pathstone Family Office’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $859K | Hold |
|
|||||
|
2023
Q2 | $1.26M | Hold |
|
|||||
|
2023
Q1 | $1.06M | Sell |
|
|||||
|
2022
Q4 | $8.18M | Hold |
|
|||||
|
2022
Q3 | $10.8M | Buy |
|
|||||
|
2022
Q2 | $5.15M | Buy |
|
|||||
|
2022
Q1 | $22M | Buy |
|
|||||
|
2021
Q4 | $18.8M | Buy |
|
|||||
|
2021
Q3 | $10.8M | Buy |
|
|||||
|
2021
Q2 | $6.78M | Buy |
|
|||||
|
2021
Q1 | $9.19M | Buy |
|
|||||
|
2020
Q4 | $2.8M | Sell |
|
|||||
|
2020
Q3 | $1.56M | Buy |
|